Navigation Links
Neurodevice Firm Checkpoint Surgical Raises $3M
Date:1/27/2012

CLEVELAND, Jan. 27, 2012 /PRNewswire/ -- Neurodevice firm Checkpoint Surgical completed a $1.7 million Series B investment round led by the NDI Healthcare Fund in December 2011, and secured non-dilutive funding of over $1.3 million, including a $1.065 million Innovation Ohio loan and a $245,000 federal grant.

(Logo: http://photos.prnewswire.com/prnh/20120127/DC43077LOGO)                                                     

Checkpoint Surgical was founded in 2009 in Cleveland, Ohio. In 2010, the company launched its flagship product, the CHECKPOINT® Stimulator/Locator, the first in a line of neuroprotective surgical devices. The CHECKPOINT® Stimulator/Locator is a state-of-the-art hand-held, intraoperative nerve and muscle stimulator that helps surgeons to locate, identify and evaluate nerves during surgery to facilitate nerve preservation and repair.

"Over the past year, the CHECKPOINT® has demonstrated market acceptance and is used in a wide range of nerve repair, ENT, orthopaedic, plastic reconstructive, and oncological surgical procedures at many of the nation's premier hospitals," said Len Cosentino, CEO and president of Checkpoint Surgical. "We've enjoyed consistent quarterly sales growth since launching the CHECKPOINT® and more than 250% growth in 2011 over 2010."

Checkpoint Surgical is using the funding to support its sales and marketing efforts and new product development. The company distributes its products in the U.S. through a combination of direct sales and distributors.

For more information, please visit www.checkpointsurgical.com.

About Checkpoint Surgical
Founded in 2009, Checkpoint Surgical's mission is to provide surgeons with state-of-the-art neurodevices to preserve nerves and evaluate nerve and muscle excitability in surgical procedures for better patient outcomes. In 2010, Checkpoint Surgical launched the CHECKPOINT® Stimulator/Locator as its flagship product in a line of proprietary neuromuscular surgical devices. For more information, visit www.checkpointsurgical.com

About NDI Healthcare Fund
Founded in 2010, the NDI Healthcare Fund is a leading venture capital and commercialization firm that focuses on innovative neurodevice technologies to address significant unmet health conditions, improve patients' lives and provide significant returns to investors. NDI is headquartered in Cleveland, Ohio with locations in North Carolina's Research Triangle and Minneapolis, Minnesota. For more information, visit www.ndimedical.com


'/>"/>
SOURCE Checkpoint Surgical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. JumpStart Invests in Checkpoint Surgical
2. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
4. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
5. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
6. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
7. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
8. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
9. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 ... company specializing in the development of innovative peptide ... and metastatic disease, today announced that it will ... Dr. Glynn Wilson , Chairman ... of the company,s business, clinical pipeline and partnering ...
(Date:3/22/2017)... March 22, 2017 Hologic, Inc. (Nasdaq: ... the acquisition of Cynosure, Inc., a leader in medical ... cash. "We are pleased to complete our ... Michael Davin and the entire Cynosure team ... growing medical aesthetics market," said Steve MacMillan , ...
(Date:3/22/2017)... TFS is pleased to announce the appointment ... , two global executive positions in Medical Affairs and Clinical Development. ... Team and will report to Dr. Montse Barceló , Chief ... ... years of medical and scientific expertise gained across leading biopharmaceutical companies ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... 2017 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had won the ‘Clinical Supply Chain Excellence’ category ... International Exhibition & Convention Centre, Singapore. The award was presented at the conference ...
(Date:3/22/2017)... ... 2017 , ... Old School Labs™, makers of the best-selling Vintage line of ... Ambassador. Theophane, who trained with Floyd Mayweather, made his professional debut in London in ... an impressive number of wins in contests in Britain, Germany and the U.S. ...
(Date:3/22/2017)... ... March 22, 2017 , ... Wash Tower Ltd. has released a series of ... Tower, the world's first standalone constant pressure bidet. , The videos in the series ... https://www.washtower.com as well as on its social media pages. , Each video ...
(Date:3/22/2017)... SC (PRWEB) , ... March 22, 2017 , ... Drs. ... expanding their patient base to accept new patients in need of skilled pediatric ... experience, India Hook Dental Care offers pediatric patients routine treatments, including cavities, sealants and ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... core lab with extensive therapeutic experience and operational excellence in oncology clinical trials, ... clinical trial for the treatment of non-small cell lung cancer and small cell ...
Breaking Medicine News(10 mins):